No-reflow: The next challenge in treatment of ST-elevation acute myocardial infarction

European Heart Journal

Volumn 29, Issue 15, 2008, Pages 1795-1797

  Abbate, Antonio ^a   Kontos, Michael C ^a   Biondi Zoccai, Giuseppe G L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; ALDOSTERONE ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITROPRUSSIDE SODIUM; THROMBOXANE A2;

ACUTE HEART INFARCTION; ARTIFICIAL EMBOLISM; BLOOD FLOW; BLOOD VESSEL INJURY; DRUG MEGADOSE; EDITORIAL; HEART FAILURE; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THROMBECTOMY; THROMBUS ASPIRATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY CIRCULATION; HUMANS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; THROMBOXANE A2;

EID: 48749115203     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn281     Document Type: Editorial

References (13)

1. DeWood MA, Spores J, Notske, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
2. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3:499- 506.
3. van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial perfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial blush grade. Circulation 1998;97:2302-2306.
4. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
5. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastuctural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 1980;62:945-952.
6. Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, Nagata S, Hori M. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002;106:1672-1677.
7. Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, Leone AM, Burzotta F, Riondino S, Pulcinelli F, Biasucci LM, Crea F. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J 2008;29:1843-1850. doi:10.1093/eurheartj/ehn325.
8. Grover GJ, Schumaker WA. Effect of thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve. J Pharmacol Exp Ther 1989;248:484-491.
9. Vilahur G, Casanì L, Badimon L. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis. Thromb Haemostasis 2007;98:662-669.
10. Rolin S, Petein M, Tchana-Sato V, Dogne JM, Benoit P, Lambermont B, Ghuysen A, Kolh P, Masereel B. BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis. J Pharmacol Exp Ther 2003;306:59-65.
11. Niccoli G, Lanza GA, Shaw S, Romagnoli E, Gioia D, Burzotta F, Trani C, Mazzari MA, Mongiardo R, De Vita M, Rebuzzi AG, Lüscher TF, Crea F. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J 2006;27:1793-1798.
12. Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007;49:1272-1278.
13. Vetrovec GW. Improving reperfusion in patients with myocardial infarction. N Engl J Med 2008;358:634-637.